To explore whether the prognostic value of CLCA4 expression combined with serum AFP level was superior to AFP alone, all the HCC patients were divided into four subgroups according to the CLCA4 expression and serum AFP level. The gene discussed is AFP; the disease is hepatocellular carcinoma.